- Home
- VNET vs CPRX Comparison
VNET vs CPRX Comparison
Compare VNET & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNET
- CPRX
- Stock Information
- Founded
- VNET 1999
- CPRX 2002
- Country
- VNET China
- CPRX United States
- Employees
- VNET N/A
- CPRX N/A
- Industry
- VNET Computer Software: Programming Data Processing
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- VNET Technology
- CPRX Health Care
- Exchange
- VNET Nasdaq
- CPRX Nasdaq
- Market Cap
- VNET 2.4B
- CPRX 2.8B
- IPO Year
- VNET 2011
- CPRX 2006
- Fundamental
- Price
- VNET $5.02
- CPRX $22.52
- Analyst Decision
- VNET Strong Buy
- CPRX Strong Buy
- Analyst Count
- VNET 3
- CPRX 7
- Target Price
- VNET $10.73
- CPRX $32.29
- AVG Volume (30 Days)
- VNET 9.6M
- CPRX 1.7M
- Earning Date
- VNET 05-28-2025
- CPRX 05-07-2025
- Dividend Yield
- VNET N/A
- CPRX N/A
- EPS Growth
- VNET N/A
- CPRX 107.94
- EPS
- VNET 0.02
- CPRX 1.31
- Revenue
- VNET $1,131,518,816.00
- CPRX $491,734,000.00
- Revenue This Year
- VNET $15.35
- CPRX $15.17
- Revenue Next Year
- VNET $21.16
- CPRX $9.61
- P/E Ratio
- VNET $53.40
- CPRX $17.19
- Revenue Growth
- VNET 11.41
- CPRX 23.49
- 52 Week Low
- VNET $1.42
- CPRX $14.47
- 52 Week High
- VNET $16.13
- CPRX $26.16
- Technical
- Relative Strength Index (RSI)
- VNET 28.02
- CPRX 48.15
- Support Level
- VNET $4.65
- CPRX $21.93
- Resistance Level
- VNET $6.26
- CPRX $23.27
- Average True Range (ATR)
- VNET 0.73
- CPRX 1.27
- MACD
- VNET -0.15
- CPRX -0.14
- Stochastic Oscillator
- VNET 10.16
- CPRX 50.60
About VNET VNET Group Inc.
VNET started as AsiaCloud in 1999 and moved to the data center business with its first self-developed data center opening in 2010. The firm listed (as 21Vianet) on the Nasdaq in April 2011, subsequently changing its name to VNET Group in 2021. It originally focused on providing data center services such as colocation and cloud services to retail clients in China, but added hyperscale customers in 2019 and now counts large Chinese hyperscalers such as Alibaba Cloud, Tencent Cloud, and Huawei Cloud as customers. At the end of June 2024, it had 48,516 self-built retail cabinets with the majority in Beijing, Shanghai, and the Greater Bay area. It also had 358 MW of wholesale capacity in service with a further 297 MW under construction and a further 489 MW held for future development.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).